|Articles|July 28, 2009
Retina Roundtable Session 4
Advertisement
Subscribe
In this fourth session, the physicians discuss their strategies for managing the flow of patients coming in each month to receive their ranibizumab injections.
Participants include:
Return to
Return to
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Coave Therapeutics reveals lead gene therapy program, CoTx-10
2
Harrow completes acquisiton of Melt Pharmaceuticals
3
Prolonged digital device use increases risk of headaches, eye pain, and fatigue in children
4
Opus Genetics doses first patient in phase 1/2 clinical trial, BIRD-1, evaluating OPGx-BEST1
5














































.png)


